Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Regulatory Compliance

Focused on FDA, PhRMA, MLR reviews, and legal guardrails for marketers.

How Pharma Can Balance Compliance With Creativity
Posted in
  • Regulatory Compliance

How Pharma Can Balance Compliance With Creativity

Innovation in the pharmaceutical industry requires creativity, experimentation, and bold scientific thinking. At the same time, … How Pharma Can Balance Compliance With CreativityRead more

by Jayshree Gondane•March 7, 2026March 7, 2026•0
How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical Industry
Posted in
  • Regulatory Compliance

How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical Industry

In the United States, pharmaceutical marketing operates under some of the strictest regulatory scrutiny in the … How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical IndustryRead more

by Jayshree Gondane•February 28, 2026February 28, 2026•0
Top 5 Reasons Biotech Companies Fail to Scale
Posted in
  • Case Studies & Trends
  • Industry Landscape
  • Regulatory Compliance

Top 5 Reasons Biotech Companies Fail to Scale

Biotechnology has emerged as one of the most innovation-driven sectors in healthcare. Advances in gene therapy, … Top 5 Reasons Biotech Companies Fail to ScaleRead more

by Jayshree Gondane•February 23, 2026February 23, 2026•0
Why Pricing Pressure Is Reshaping Drug Commercialization
Posted in
  • Industry Landscape
  • Regulatory Compliance

Why Pricing Pressure Is Reshaping Drug Commercialization

The United States pharmaceutical market has historically provided manufacturers with substantial pricing flexibility compared to other … Why Pricing Pressure Is Reshaping Drug CommercializationRead more

by Jayshree Gondane•February 23, 2026February 23, 2026•0
Why Many Drugs Fail Despite Positive Trial Results
Posted in
  • Case Studies & Trends
  • Regulatory Compliance

Why Many Drugs Fail Despite Positive Trial Results

Over 90 percent of drugs that show promise in early-phase clinical trials fail to reach the … Why Many Drugs Fail Despite Positive Trial ResultsRead more

by Jayshree Gondane•February 22, 2026February 22, 2026•0
Why Drugs Fail After Phase I in the U.S. Market
Posted in
  • Industry Landscape
  • Regulatory Compliance

Why Drugs Fail After Phase I in the U.S. Market

In the United States, roughly 12 percent of drugs that enter clinical testing ultimately receive approval … Why Drugs Fail After Phase I in the U.S. MarketRead more

by Jayshree Gondane•February 16, 2026February 16, 2026•0
Why Regulatory Delays Are Only Part of the U.S. Clinical Trial Problem
Posted in
  • Regulatory Compliance
  • Strategy & Execution

Why Regulatory Delays Are Only Part of the U.S. Clinical Trial Problem

When a development program misses projected timelines, the explanation often centers on regulatory review. FDA feedback … Why Regulatory Delays Are Only Part of the U.S. Clinical Trial ProblemRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0
Why U.S. Clinical Trial Timelines Keep Getting Longer
Posted in
  • Industry Landscape
  • Regulatory Compliance

Why U.S. Clinical Trial Timelines Keep Getting Longer

The average time required to bring a new medicine from discovery to approval in the United … Why U.S. Clinical Trial Timelines Keep Getting LongerRead more

by Jayshree Gondane•February 13, 2026February 13, 2026•0
How Poor Trial Design Increases Drug Development Costs
Posted in
  • Case Studies & Trends
  • Regulatory Compliance

How Poor Trial Design Increases Drug Development Costs

In pharmaceutical development, clinical trials serve as the backbone of bringing a new therapy from concept … How Poor Trial Design Increases Drug Development CostsRead more

by Jayshree Gondane•February 10, 2026February 10, 2026•0
How Pharma Marketing Impacts Clinical Trial Success
Posted in
  • Digital Transformation
  • Regulatory Compliance

How Pharma Marketing Impacts Clinical Trial Success

In the United States, nearly 80 percent of clinical trials fail to meet their original enrollment … How Pharma Marketing Impacts Clinical Trial SuccessRead more

by Jayshree Gondane•February 8, 2026February 8, 2026•0

Posts pagination

1 2 … 5 Next

Recent Posts

  • Understanding Prior Authorization in Pharmaceutical Sales
  • Side Hustles for Pharmaceutical Sales Representatives
  • How to Handle Burnout in Pharmaceutical Sales
  • Work-Life Balance Tips for Pharmaceutical Sales Reps
  • Continuing Education Options for Pharma Professionals

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A